This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mercer, K. Articles by Pritchard, C. Search for Related Content PubMed PubMed Citation Articles by Mercer, K. Articles by Pritchard, C.

Expression of Endogenous Oncogenic ^V600EB-raf Induces Proliferation and Developmental Defects in Mice and Transformation of Primary Fibroblasts

Departments of ¹ Biochemistry and ² Genetics, University of Leicester, University Road, Leicester, United Kingdom and ³ Cancer Research UK Centre for Cell and Molecular Biology, Institute of Cancer Research, London, United Kingdom

Correspondence: Catrin Pritchard, Department of Biochemistry, University of Leicester, University Road, Leicester, LE17RH, United Kingdom. Phone: 44-116-252-3489; Fax: 44-116-252-3369; E-mail: cap8{at}le.ac.uk or Richard Marais, Cancer Research UK Centre for Cell and Molecular Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom. Phone: 44-207-878-3856; Fax: 44-207-352-3299; Email: rmarais{at}icr.ac.uk.

Mutations of the human B-RAF gene are detected in 8% of cancer samples, primarily in cutaneous melanomas (70%). The most common mutation (90%) is a valine-to-glutamic acid mutation at residue 600 (V600E; formerly V599E according to previous nomenclature). Using a Cre/Lox approach, we have generated a conditional knock-in allele of ^V600EB-raf in mice. We show that widespread expression of ^V600EB-Raf cannot be tolerated in embryonic development, with embryos dying 7.5 dpc. Directed expression of mutant ^V600EB-Raf to somatic tissues using the IFN-inducible Mx1-Cre mouse strain induces a proliferative disorder and bone marrow failure with evidence of nonlymphoid neoplasia of the histiocytic type leading to death within 4 weeks of age. However, expression of mutant B-Raf does not alter the proliferation profile of all somatic tissues. In primary mouse embryonic fibroblasts, expression of endogenous ^V600EB-Raf induces morphologic transformation, increased cell proliferation, and loss of contact inhibition. Thus, ^V600EB-Raf is able to induce several hallmarks of transformation in some primary mouse cells without evidence for the involvement of a cooperating oncogene or tumor suppressor gene. (Cancer Res 2005; 65(24): 11493-500)

This article has been cited by other articles:

				Y. Fukuyo, M. Inoue, T. Nakajima, R. Higashikubo, N. T. Horikoshi, C. Hunt, A. Usheva, M. L. Freeman, and N. Horikoshi Oxidative Stress Plays a Critical Role in Inactivating Mutant BRAF by Geldanamycin Derivatives Cancer Res., August 1, 2008; 68(15): 6324 - 6330. [Abstract] [Full Text] [PDF]

				D. L. Waning, B. Li, N. Jia, Y. Naaldijk, W. S. Goebel, H. HogenEsch, and K. T. Chun Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis Blood, July 15, 2008; 112(2): 320 - 329. [Abstract] [Full Text] [PDF]

				T. Rajakulendran, M. Sahmi, I. Kurinov, M. Tyers, M. Therrien, and F. Sicheri CNK and HYP form a discrete dimer by their SAM domains to mediate RAF kinase signaling PNAS, February 26, 2008; 105(8): 2836 - 2841. [Abstract] [Full Text] [PDF]

				E. C. Torchia, K. Boyd, J. E. Rehg, C. Qu, and S. J. Baker EWS/FLI-1 Induces Rapid Onset of Myeloid/Erythroid Leukemia in Mice Mol. Cell. Biol., November 15, 2007; 27(22): 7918 - 7934. [Abstract] [Full Text] [PDF]

				H. Ji, Z. Wang, S. A. Perera, D. Li, M.-C. Liang, S. Zaghlul, K. McNamara, L. Chen, M. Albert, Y. Sun, et al. Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models Cancer Res., May 15, 2007; 67(10): 4933 - 4939. [Abstract] [Full Text] [PDF]

				M. Yancovitz, J. Yoon, M. Mikhail, W. Gai, R. L. Shapiro, R. S. Berman, A. C. Pavlick, P. B. Chapman, I. Osman, and D. Polsky Detection of Mutant BRAF Alleles in the Plasma of Patients with Metastatic Melanoma J. Mol. Diagn., April 1, 2007; 9(2): 178 - 183. [Abstract] [Full Text] [PDF]

				K. M. Haigis, I. I. Wistuba, and J. M. Kurie Lung premalignancy induced by mutant B-Raf, what is thy fate? To senesce or not to senesce, that is the question Genes & Dev., February 15, 2007; 21(4): 361 - 366. [Full Text] [PDF]

				D. Dankort, E. Filenova, M. Collado, M. Serrano, K. Jones, and M. McMahon A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors Genes & Dev., February 15, 2007; 21(4): 379 - 384. [Abstract] [Full Text] [PDF]

				I. Hmitou, S. Druillennec, A. Valluet, C. Peyssonnaux, and A. Eychene Differential Regulation of B-Raf Isoforms by Phosphorylation and Autoinhibitory Mechanisms Mol. Cell. Biol., January 1, 2007; 27(1): 31 - 43. [Abstract] [Full Text] [PDF]